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pH salivary analysis of subjects suffering from Sjögren’s Syndrome 
and laryngopharyngeal reflux
Abstract
Marco Antonio dos Anjos Corvo1, Claudia Alessandra Eckley2, Bianca Maria Liquidato3, Gustavo Leão 
Castilho4, Cibelle Nunes de Arruda5 
Saliva is one of the components for the digestive homeostasis. Recent studies have shown that 
patients with laryngopharyngeal reflux (LPR) present a drop in salivary pH. Patients with Sjögren´s 
syndrome (SS) are a potential clinical research model for xerostomia and its laryngeal and pharyngeal 
consequences. The aim was to evaluate the characteristics of saliva of patients with SS and LPR. 
Methods: 19 patients with SS plus LPR, and 12 healthy controls had their saliva studied prospectively 
for volume and pH. Two salivary samples were obtained from each participant: whole unstimulated 
saliva(WUS) and whole stimulated saliva(WSS) while chewing parafilm M®. All the participants were 
females. 
Results: Mean age was 60 years (study group) and 44 years (control). LPR was diagnosed on all 19 
subjects. The mean pH of WUS was 7.53 (SS) and 7.57 (controls), raising to 7.87 and 7.83 respectively 
after stimulation. The mean salivary volume of patients with SS was 1.27 mL (WUS) and 3.78 mL 
(WSS), whereas controls had a significantly higher salivary volume both before and after stimuli.
Conclusion: A very high prevalence of LPR was found in patients with SS, which is probably caused 
by a uniform drop in salivary volume and all its contents, rather than a specific deficiency in its 
components, as shown previously in patients without SS.
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INTRODUCTION 
Saliva plays a fundamental role in the digestive 
system’s homeostasis, for its inorganic content - made 
up of water and bicarbonate ions, but primarily by its 
organic and protein make up1. Thus, one might question 
the clinical situation caused by xerostomia on the basic 
salivary functions of food bolus lubrication, on the begin-
ning of the enzymatic digestion, buffering capacity and 
local immune response1. Previous studies indicate that 
low saliva volumes reduce the esophageal-salivary reflex 
effectiveness and could contribute to the occurrence of 
oral, esophageal and dyspeptic diseases2,3.
Xerostomia is defined as a subjective sensation of 
dry mouth (from the Greek xeros - dry stoma - mouth)4.5. 
It may be present in various diseases, among which we 
stress Sjögren’s syndrome (SS)1,4-10. Of probable autoimmu-
ne origin, SS affects the exocrine glands, which undergo 
progressive lymphoplasmacytic infiltration and leads to 
functional failures9,10. Since the salivary glands are fre-
quently affected by infiltration, the disease is recognized 
for causing clinically noteworthy xerostomia9,10.
Some authors have reported higher prevalence of 
gastroesophageal reflux disease (GERD) in populations 
with SS11-13. However, with regards to laryngopharyngeal 
reflux (LPR), only rare reports mention its occurrence as 
frequent in subjects with SS, with no specific studies de-
signed to establish this correlation14-17.
For individuals with xerostomia, Eckley & Costa18 
noticed significant drops in the pH and in the salivary 
volume of patients with LPR, when compared to normal 
individuals. Moreover, these changes seem to be a respon-
se to reflux, and not a primary deficiency, because after 
controlling the disease, pH and salivary volume go back 
to normal19. However, in SS individuals, it is not known 
how saliva could interfere in the balance of the laryngeal 
and esophageal coating epithelium. Would there be local 
tissue damage simply because of the volumetric reduction 
in salivary volume or would there be changes in the sa-
livary make up involved in the genesis and maintenance 
of the findings?
Our hypothesis is that there would be some specific 
change in the saliva of individuals with SS which would 
cause a reduction in laryngeal and pharyngeal protection, 
making some of these individuals more susceptible to LPR, 
as it seems to happen with individuals without xerosto-
mia18,20. The early identification of these individuals in risk 
by studying their salivary characteristics could be of high 
importance for preventing the complications associated 
with the laryngopharyngeal reflux, enhancing the quality 
of life of individuals with Sjögren’s syndrome.
The present paper aims at comparing the salivary 
volume and pH of individuals with Sjögren’s syndrome and 
laryngopharyngeal reflux to those of healthy individuals.
MATERIALS AND METHODS
After approval by the Ethics in Research with Hu-
man Beings’ Committee of our institution (Project number 
034/07), a total of 36 adult patients diagnosed with Sjögren 
were investigated in a cross-section manner. The patients 
were consecutively and randomly selected by telephone 
call, from the database of the stomatology wards of a 
tertiary university hospital, between January 2007 and 
December of 2009. We admitted all the patients who met 
the inclusion and exclusion criteria, after a statement about 
the objectives, methodologies and risks.
Inclusion factors were: adult patients with hyposa-
livation and a confirmed diagnosis of Sjögren’s syndrome 
by the current diagnoses criteria of the American-European 
consensus21.
The exclusion factors were other conditions which 
could cause chronic laryngopharyngitis, such as: smoking, 
drinking alcoholic beverages, exposure to abrasive inha-
ling chemicals and overt allergic or infectious agents20. In 
addition, we took off the study those patients who were 
unable to produce a minimum amount of saliva for sam-
pling and biochemical analysis, patients whom we could 
suspend prokinetic or proton pump inhibitor drugs, pa-
tients submitted to salivary gland surgery and patients with 
pre-neoplastic and neoplastic laryngeal and pharyngeal 
lesions (current or previously treated)18,20,22.
Of the initially 36 selected patients with SS by the 
criteria used, 17 were withdrawn from the study by the 
conditions described in Table 1.
Table 1. Reasons for excluding patients with Sjögren’s 
syndrome initially selected by the study.
Abandoning the protocol 5
Insufficient saliva production for analysis purposes 3
C Hepatitis diagnosed during the protocol 3
Neoplasia diagnosed during the protocol 2
Return to smoking during the protocol 2
Death before finishing the protocol 1
Previous gastric fundoplication 1
Total 17
The patients answered a detailed questionnaire 
about laryngopharyngeal and digestive symptoms sug-
gestive of GERD and LPR, and subsequently underwent 
a thorough ENT examination and rigid laryngoscopy 
(without topical anesthesia). We used the flexible nasal-
laryngoscope only in cases of hyperreflexia or impossibility 
to visualize the segment with the telescope.
Two consecutive samples of whole saliva were 
obtained from each participant: the first, unstimulated 
whole saliva (UWS) and second, stimulated whole saliva 
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(SWS), mechanically by chewing a 25 cm2 piece parafilm 
M® (Pechiney Plastic Packing Chicago IL, USA)23.
Collection was always performed in the morning 
and with the patient fasting for at least eight hours. The 
patient was instructed not to brush his/her teeth or use 
mouthwash in the morning of saliva collection. The me-
thod of collection was the one previously described by 
Eckley et al.18-20
The UWS and SWS samples were collected by 
asking the patient to “spit” freely in a collection bottle 
the entire saliva volume produced during the 10-minute 
period. To preserve their rheological and biochemical 
characteristics, salivary samples were stored in a refrige-
rator at 5 degrees Celsius, until they could be processed 
and analyzed.
The processing was done in the same saliva col-
lection period by centrifugation for 10 minutes (3500 rpm 
– Excelsa II centrifuge - Fanem - Brazil) for sedimentation 
of cellular debris; the supernatant was separated for pH 
and volume measurement. Salivary volume measurement 
was made using pipettes and graduated test tubes, being 
recorded in milliliters24. Salivary pH was measured using 
a digital pH meter (Denver Instrument Company, Model: 
Basic pH meter, Arvada, CO, USA).
The LPR diagnosis was made based on laryngeal 
signs and symptoms, using two research instruments, the 
rate of reflux symptoms (reflux symptom index - RSI)25, and 
the Reflux Finding Score (RFS)26, both previously validated 
in the literature for the English language25,26. Symptoms 
which added scores were equal to or higher than 13 in 
the RSI25 were considered positive for LPR, and laryngeal 
signs which added scores were higher than or equal to 
seven in the RFS26.
Laryngopharyngeal symptoms and direct laryn-
goscopy signs matched the results of endoscopy and/or 
dual-channel 24-hour esophageal pH monitoring.
With technical support from a specific professional, 
the results were plotted and analyzed using parametric and 
non-parametric statistical methods for variable analyses 
(Student’s t test and Wilcoxon test). We considered a “p” 
value lower than or equal to 0.05 as significant.
To determine the importance of the results for the 
SS group examined we also studied a group of 12 healthy 
female volunteers, who were selected by following the 
same exclusion criteria set forth above. Moreover, none 
of the volunteers met the diagnostic criteria used for SS. 
All were also submitted to RSI25 and RFS26 and to rule out 
the presence of LPR, a condition for participating in the 
control group. Saliva collection and the salivary parameters 
studied were similar to those described for the study group.
RESULTS
All the 19 individuals in this study were females, 
with a mean age of 60 years (varying between 49 and 74 
years). Nine patients had primary SS, seven cases were 
secondary to rheumatoid arthritis, two were secondary 
to systemic lupus erythematous and one to scleroderma. 
The mean diagnosis time for the individuals with SS at the 
time when the present study was analyzed was 58 months 
(4 years and 10 months), with a median of 5 years and 4 
months and standard deviation of 2 years and 5 months.
The control group was made up of 12 healthy 
women, with mean age of 44 years (26 to 62 years), me-
dian of 42 years and standard deviation of 11.5; without 
laryngeal signs or symptoms of LPR. Mean RSI was zero 
and the mean RFS was 1.75, varying between zero and 
three points, both confirming that there was no posterior 
laryngitis.
There was a difference between the mean age of 
the study group and that of the control group. Even then, 
when we correlated the age of all the individuals (study 
and control groups) with the quantitative salivary variables 
studied (volume and pH), the Pearson’s correlation index 
showed low values, indicating that both groups could be 
compared vis-à-vis these variables (Table 2).
Table 2.Pearson’s correlation index values in the comparison 
between the age of the individuals and the salivary samples 
investigated, in the total non-stimulated saliva (TNSS) and total 
stimulated saliva (TSS).
TNSS TSS
Compared variable Volume pH Volume pH
Pearson’s correlation -0.370 -0.047 -0.419 0.054
In the study group, the mean RSI was 19.5, varying 
between 13 and 30 points. The mean RFS was 11.56, va-
rying between eight and eighteen points.
Of the eight patients with reflux esophagitis in the 
study group, four had non-erosive esophagitis and four 
and the erosive type (Los Angeles grade A), there was no 
one with Barret’s esophagus in the series. Because they 
had RSI and RFS suggestive of laryngopharyngeal reflux, 
with UGE (upper gastrointestinal endoscopy) confirming 
gastroesophageal disease, in eight individuals we con-
firmed the laryngopharyngeal reflux. In the remaining 
11 individuals in whom UGE was not changed, we did 
manometry and esophageal pH measuring, according to 
the methodology utilized.
As to the esophageal manometry, seven patients 
had a normal exam, two patients had hypotonia of the 
lower esophageal sphincter, and two had mild esophageal 
dysmotility. However, as to the double-sensor esophageal 
pH probe study, the result was uniform, because all the 11 
patients in the study group had pathological reflux episo-
des in the proximal sensor, making up the LPR diagnosis. 
Only three of these individuals had reflux in pathological 
levels also in the distal sensor, which configures GERD 
and LPR together.
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When we analyzed the individuals with SS as to 
disease subtype (primary or secondary), we did not notice 
a statistically significant difference, by the Mann-Whitney 
test, in characterizing the sample as to age (p=0.549), as 
to RSI (p=0.447) and as to RFS (p=0.400). Since the SS 
subtypes were statistically equal for the salivary variables 
analyzed (volume and pH), we considered the individuals 
with SS in the same group in order to compare them with 
the control group.
Salivary pH and volume results are presented on 
Figures 1 and 2, and are described below.
a mean value of 7.53, varying between 6.40 – 8.40 
(sd=0.51), and TSS was 7.87, varying between 6.67 and 
8.43 (sd=0.47), and this difference was also statistically 
significant (p =0.002).
In the group of healthy volunteers, the mean salivary 
volume of the NSSV was 4.02, varying between 1.6 and 
8.0mL, and the STS was 11.96 mL, varying between 4.5-
19.0mL (p=0.002). Now, the mean NSTS pH was 7.57, 
varying between 6.83 and 7.92; and the mean value of the 
TSS was 7.93, varying between 7.56 and 8.17 (p=0.004). All 
the above-studied variables in the control group showed 
statistically significant differences between the stimulated 
and the non-stimulated salivary samples.
As expected, SS patients had a statistically lower 
NSTS and STS mean volumes when compared to the 
control individuals (p<0.001). Nonetheless, there was no 
statistically significant difference in the saliva pH between 
the study and the control groups, both for the total non-
stimulated and the stimulated total saliva (p>0.1).
DISCUSSION 
The motivation to go more in-depth in understan-
ding this topic stemmed from the need to understand LPR 
genesis more in-depth, and in the empirical observation 
of some patients with LPR being followed up, who had 
hyposalivation, according to the studies carried out by 
Eckley, in 200419. Thus, the project was conceived to 
conjugate the research objectives in salivary biochemical 
factors in the LPR genesis, with the need to offer our 
SS patients a better understanding of their disease and all 
the manifestations surrounding them.
For the LPR diagnosis, we considered the laryn-
goscopic signs and symptoms translated by the RSI25 and 
RFS26 instruments, respectively; nonetheless in association 
with the UDTE, esophageal pressure and 24-hour double 
channel esophageal pH probe data. We agree with the 
current trend that the RFS seems to be a good index to 
assess the presence of endoscopic signs of laryngitis, wi-
thout this laryngeal inflammation being necessarily linked 
to reflux of the gastroduodenal content such as etiology 
(reason to adopt such strict exclusion criteria)17,22. Thus, 
the present study agrees with the recent publications by 
Gupta & Sataloff17 and Ali22 as admitting to a suspicion of 
LPR only when the RFS values higher than seven were 
associated with characteristic symptoms, with the RSI 
greater than 13 which still relates to the patient’s clinical 
complaint as an important suspicion for diagnosis. Even 
if ideal, the conjugation of these two instruments was pa-
ramount to establish the LPR suspicion, which was later 
corroborated by UDTE and the double channel 24 hour 
esophageal pH probe.
Although rare, the literature had already considered 
them possible laryngeal manifestations of the SS. In a 2003 
Figure 1. Salivary mean volume in individuals with Sjögren (study group) 
and in healthy individuals - TNSS- Total Non-Stimulated Saliva
TSS – Total Stimulated Saliva.
Figure 2. Mean salivary ph in individuals with Sjögren (study group) 
and in healthy individuals – TNSS – Total Non-Stimulated Saliva
TSS- Total Stimulated Saliva.
The total unstimulated saliva volume (TUSV) of the 
individuals with SS varied between 0.1 and 4.1 mL (mean 
value of 1.27 mL) (sd=1.06). The mean Total Stimulated 
Saliva (TSS) volume was 3.78 mL, varying between 0.1 
and 10.3 mL (sd=2.87). This difference was statistically 
significant (p=0.009). TUSV pH in patients with SS showed 
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publication, Belafsky & Postma11 empirically recognized 
a high prevalence of LPR and esophageal dysmotility in 
patients with SS11. In the current series, only two of the 19 
patients with SS had esophageal dysmotility.
In 2005, Ogut et al.12, submitted 77 patients with 
SS to RSI and RFS search criteria, concluding that in this 
subgroup, the score values were significantly higher when 
compared to the normal individuals studied. The present 
study achieved great notability because of the expressive 
series reported, and it also stimulated the current study 
to try to understand the reason for such a high referred 
association.
Therefore, considering the previous literature data, 
and considering the protective properties of saliva to the di-
gestive system18,20, we expected to find laryngopharyngeal 
changes in patients with SS. The initial hypothesis was that 
the association with SS with LPR would happen because 
of qualitative and not quantitative salivary deficiency. 
However, the current series did not allow to establish a 
correlation, since all the patients studied had LPR.
Analyzing the salivary data, we noticed that the 
mean volume of the TNSS samples from patients with SS 
was really low (1.27mL), with pH values slightly alkaline 
(mean value of 7.53). Even if these patients suffer from a 
saliva-production-limiting disease, the masticatory stimu-
lation employed was able to increase the saliva volume 
(mean of 3.78mL), with a statistically significant differen-
ce. The mean TSS pH value went up to 7.87, reflecting a 
greater alkalinity of the fluid after the stimulus. This pH 
increase is particularly relevant for SS patients, if we con-
sider the large prevalence of LPR seen in the study and 
the need for these patients to, theoretically, having greater 
efficiency in salivary buffering.
Since all SS patients had a behavior similar to that 
of LPR, comparing TNS and TSS variables of individuals 
with SS and without LPR were fundamental in the attempt 
to interpret the findings.
In relation to the results from the volumes obtained, 
the TNSS volume from SS individuals was reduced, sho-
wing a mean value of 1.27mL in a 10-minute collection. 
This value was statistically lower when compared to that 
from the control group, as to be expected for populations 
with SS.
About the pH of the salivary samples, it was noticed 
that the masticatory stimulus did not cause a statistically 
significant difference within the groups analyzed (control 
and study). Moreover, when compared to healthy indivi-
duals, the salivary samples of individuals with SS who had 
statistically equal pH values. Thus, differently than patients 
with LPR and without xerostomia, who had more acid 
saliva pH values in comparison with normal individuals, 
the patient with SS and with LPR did not have this altered 
mean pH value19,20,27. In other words, changes in salivary 
pH did not seem to be involved in the greater occurrence 
of LPR in patients with SS, suggesting a different patho-
physiology from the LPR for this special group.
The rarity of SS in the world and the lack of official 
data both on disease prevalence as to its other particulari-
ties in Brazil make the recording of the reflux behavior in 
this subpopulation a topic very little explored before9,10. 
The results presented in this study represent part of an on-
going study about the organic and inorganic characteristics 
of patients with SS, and its influence in the genesis of LPR 
and GERD. Thus, greater details on the pathophysiology 
of the disease in this subgroup of patients with SS are 
awaited, as new data become available.
CONCLUSIONS
Based on the present study, we concluded that there 
was no statistically significant difference in the salivary pH 
of individuals with Sjögren syndrome and healthy individu-
als, both in the non-stimulated total saliva as well as in 
the total stimulated saliva. This suggests that the laryngo-
pharyngeal reflux may have a unique pathophysiology in 
SS individuals, possibly associated with the global drop in 
salivary volume and all its components.
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